Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
| Revenue (TTM) | $2.89B |
| Gross Profit (TTM) | $1.64B |
| EBITDA | $214.00M |
| Operating Margin | 1.36% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 1.05 |
| Price-to-Sales (TTM) | 1.28 |
| EV/Revenue | 1.363 |
| EV/EBITDA | 30.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 13.10% |
| Shares Outstanding | $280.81M |
| Float | 0 |
| % Insiders | 90.51% |
| % Institutions | 0.06% |